Skip to content

The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion.

The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion. - The study of treatment and prognosis for AMD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014436
Enrollment
100
Registered
2014-07-01
Start date
2014-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Macular Degeneration

Interventions

None listed

Sponsors

Department of Ophthalmology and Visual Sciences Yamagata
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with age-related macular degeneration.

Exclusion criteria

Exclusion criteria: Patients who disagreed with this study.

Design outcomes

Primary

MeasureTime frame
Visual acuity and central retinal thickness before and after each treatment.

Secondary

MeasureTime frame
Disease type and history of ophthalmic treatment and systemic factors.

Countries

Japan

Contacts

Public ContactTakanori Murakami

Yamagata University Faculty of Medicine Department of Ophthalmology and Visual Sciences

ikekenkyu@jm.kj.yamagata-u.ac.jp023-628-5047

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026